Delivery Order SPE2DB24D3013-SPE2DB25FFQNM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $1,709.46. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $12,700.91. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a $7,437.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive, competitively awarded delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,577.74. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The award will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,418.92 under a firm fixed-price contract. This award represents a non-set-aside competitive procurement and is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the company's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $7,968.00. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The company is a major pharmaceutical...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,418.92. This is a firm fixed price delivery order with no set-aside designation, issued under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of...
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQNMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,920.04 under firm fixed price terms. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support across the Defense Health Agency and related federal healthcare systems. The company maintains an extensive portfolio of delivery orders under its DLA prime indefinite delivery vehicle, which encompasses a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Dupixent, a biologic medication used in the treatment of atopic dermatitis and other inflammatory conditions, demonstrates the company's role in supplying specialized pharmaceutical products to support military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/12/25 |